Severity of Analgesic Dependence and Medication-overuse Headache

Christofer Lundqvist, Michael Gossop, Michael Bjørn Russell, Jørund Straand, Espen Saxhaug Kristoffersen, Christofer Lundqvist, Michael Gossop, Michael Bjørn Russell, Jørund Straand, Espen Saxhaug Kristoffersen

Abstract

Background and aims: Medication-overuse headache (MOH) is a common chronic headache caused by overuse of headache analgesics. It has similarities with substance dependence disorders. The treatment of choice for MOH is withdrawal of the offending analgesics. Behavioral brief intervention treatment using methods adapted from substance misuse settings is effective. Here we investigate the severity of analgesics dependence in MOH using the Severity of Dependence Scale (SDS), validate the SDS score against formal substance dependence diagnosis based on the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) and examine whether the SDS predicts successful withdrawal.

Methods: Representative recruitment from the general population; 60 MOH patients, 15 chronic headache patients without medication overuse and 25 population controls. Headaches were diagnosed using the International Classification of Headache Disorders, medication use was assessed and substance dependence classified according to the DSM-IV. The SDS was scored by interviewers blinded to patient group. Descriptive statistics were used and validity of the SDS score assessed against a substance dependence diagnosis using ROC analysis.

Results: Sixty-two percent of MOH patients overused simple analgesics, 38% centrally acting analgesics (codeine, opiates, triptans). Fifty percent of MOH patients were classified as DSM-IV substance dependent. Centrally active medication and high SDS scores were associated with higher proportions of dependence. ROC analysis showed SDS scores accurately identified dependence (area under curve 88%). Lower SDS scores were associated with successful withdrawal (P = 0.004).

Conclusions: MOH has characteristics of substance dependence which should be taken into account when choosing treatment strategy.

Trial registration: Based on data collected in previously reported randomized BIMOH trial (; in the present manuscript, Clinical trials registration number: NCT01314768). The present part, however, represents observational data and is not a treatment trial.

Conflict of interest statement

The authors report no conflict of interests.

Figures

FIGURE 1
FIGURE 1
ROC analyses Severity of Dependence Scale (SDS) scores versus DSM-IV dependence.
FIGURE 2
FIGURE 2
Severity of Dependence Scale (SDS) scores at the main data collection interview for all cases split by diagnosis. Significant differences between groups: ANOVA, P < 0.001; ∗∗∗post hoc test: P < 0.001 versus MOH. Patient groups: CHC, chronic headache (without medication overuse) controls; MOH, medication-overuse headache; PC, population controls (without chronic headache).
FIGURE 3
FIGURE 3
Severity of Dependence Scale (SDS) scores at the main data collection interview for all cases split by medication group. Significant differences between groups: ANOVA, P < 0.001; ∗∗∗post hoc test: P < 0.001 versus no overuse.

References

    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders DSM-IV, 4th edition, Text revision. Washington, DC: American Psychiatric association; 2000.
    1. Biagianti B, Grazzi L, Gambini O, et al. Orbitofrontal dysfunction and medication overuse in patients with migraine. Headache 2012; 52:1511–1519.
    1. Calabresi P, Cupini LM. Medication-overuse headache: similarities with drug addiction. Trends Pharmacol Sci 2005; 26:62–68.
    1. Carlsen LN, Munksgaard SB, Jensen RH, et al. Complete detoxification is the most effective treatment of medication-overuse headache: a randomized controlled open-label trial. Cephalalgia 2018; 38:225–236.
    1. Chiang CC, Schwedt TJ, Wang SJ, et al. Treatment of medication-overuse headache: a systematic review. Cephalalgia 2016; 36:371–386.
    1. Colas R, Munoz P, Temprano R, et al. Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology 2004; 62:1338–1342.
    1. Cupini LM, Sarchielli P, Calabresi P. Medication overuse headache: neurobiological, behavioural and therapeutic aspects. Pain 2010; 150:222–224.
    1. De Las Cuevas CC, Sanz EJ, de la Fuente JA, et al. The Severity of Dependence Scale (SDS) as screening test for benzodiazepine dependence: SDS validation study. Addiction 2000; 95:245–250.
    1. Diener HC. Detoxification for medication overuse headache is not necessary. Cephalalgia 2012; 32:423–427.
    1. Diener HC, Dodick DW, Goadsby PJ, et al. Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse. Cephalalgia 2009; 29:1021–1027.
    1. Diener HC, Holle D, Solbach K, et al. Medication-overuse headache: risk factors, pathophysiology and management. Nat Rev Neurol 2016; 12:575–583.
    1. Frich JC, Kristoffersen ES, Lundqvist C. GPs’ experiences with brief intervention for medication-overuse headache: a qualitative study in general practice. Br J Gen Pract 2014; 64:e525–e531.
    1. Fuh JL, Wang SJ. Dependent behavior in patients with medication-overuse headache. Curr Pain Headache Rep 2012; 16:73–79.
    1. Fuh JL, Wang SJ, Lu SR, et al. Does medication overuse headache represent a behavior of dependence? Pain 2005; 119:49–55.
    1. Giraudon I, Lowitz K, Dargan PI, et al. Prescription opioid abuse in the UK. Br J Clin Pharmacol 2013; 76:823–824.
    1. Gossop M, Darke S, Griffiths P, et al. The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 1995; 90:607–614.
    1. Grande RB, Aaseth K, Saltyte-Benth J, et al. The severity of dependence scale detects people with medication overuse. The Akershus study of chronic headache. J Neurol Neurosurg Psychiatry 2009; 80:784–789.
    1. Hagen K, Albretsen C, Vilming ST, et al. Management of medication overuse headache: 1-year randomized multicentre open-label trial. Cephalalgia 2009; 29:221–232.
    1. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018; 38:1–211.
    1. Jonsson P, Hedenrud T, Linde M. Epidemiology of medication overuse headache in the general Swedish population. Cephalalgia 2011; 31:1015–1022.
    1. Kaye S, Darke S. Determining the diagnostic cut-off on the Severity of dependence scale (SDS) for cocaine dependence. Addiction 2002; 97:727–731.
    1. Kristoffersen ES, Straand J, Benth JS, et al. Study protocol: Brief intervention for medication overuse headache—a double-blinded cluster randomised parallel controlled trial in primary care. BMC Neurol 2012; 12:70.
    1. Kristoffersen ES, Straand J, Vetvik KG, et al. Brief intervention for medication-overuse headache in primary care. The BIMOH study: a double-blind pragmatic cluster randomised parallel controlled trial. J Neurol Neurosurg Psychiatry 2015; 86:505–512.
    1. Lawrinson P, Copeland J, Gerber S, et al. Determining a cut-off on the Severity of Dependence Scale (SDS) for alcohol dependence. Addict Behav 2007; 32:1474–1479.
    1. Lundqvist C, Grande RB, Aaseth K, et al. Dependence scores predict prognosis of medication overuse headache: a prospective cohort from the Akershus study of chronic headache. Pain 2012; 153:682–686.
    1. Martin G, Copeland J, Gates P, et al. The Severity of Dependence Scale (SDS) in an adolescent population of cannabis users: Reliability, validity and diagnostic cut-off. Drug Alcohol Depend 2006; 83:90–93.
    1. Murthy VH. Ending the opioid epidemic—a call to action. N Engl J Med 2016; 375:2413–2415.
    1. Olesen J. Detoxification for medication overuse headache is the primary task. Cephalalgia 2012; 32:420–422.
    1. Petrovic P, Kalso E, Petersson KM, et al. A prefrontal non-opioid mechanism in placebo analgesia. Pain 2010; 150:59–65.
    1. Radat F, Creac’h C, Guegan-Massardier E, et al. Behavioral dependence in patients with medication overuse headache: a cross-sectional study in consulting patients using the DSM-IV criteria. Headache 2008; 48:1026–1036.
    1. Radat F, Lanteri-Minet M. What is the role of dependence-related behavior in medication-overuse headache? Headache 2010; 50:1597–1611.
    1. Rossi P, Di LC, Faroni J, et al. Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia 2006; 26:1097–1105.
    1. Saper JR, Lake AE., III Medication overuse headache: type I and type II. Cephalalgia 2006; 26:1262.
    1. Sarchielli P, Messina P, Cupini LM, et al. Sodium valproate in migraine without aura and medication overuse headache: a randomized controlled trial. Eur Neuropsychopharmacol 2014; 24:1289–1297.
    1. Scher AI, Rizzoli PB, Loder EW. Medication overuse headache: an entrenched idea in need of scrutiny. Neurology 2017; 89:1296–1304.
    1. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59 suppl 20:22–33. quiz 34–57.
    1. Silberstein SD, Blumenfeld AM, Cady RK, et al. OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline. J Neurol Sci 2013; 331:48–56.
    1. Tassorelli C, Jensen R, Allena M, et al. A consensus protocol for the management of medication-overuse headache: evaluation in a multicentric, multinational study. Cephalalgia 2014; 34:645–655.
    1. Topp L, Mattick RP. Choosing a cut-off on the Severity of Dependence Scale (SDS) for amphetamine users. Addiction 1997; 92:839–845.
    1. Zubieta JK, Stohler CS. Neurobiological mechanisms of placebo responses. Ann N Y Acad Sci 2009; 1156:198–210.

Source: PubMed

3
Abonnieren